Security Snapshot

INTUITIVE SURGICAL INC - Common Stock (ISRG) Institutional Ownership

CUSIP: 46120E602

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

2,285

Shares (Excl. Options)

292,328,806

Price

$460.99

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.08%
Share change
-5,371,335
Value change
-$3,247,808,601
Number of holders
2,285
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
355,159,132
SEC-reported price per share
$432.27
Insider filing price
$432.27
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • ISRG - INTUITIVE SURGICAL INC - Common Stock is tracked under CUSIP 46120E602.
  • 2285 institutions reported positions in Q1 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2,397 to 2,285 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $168,934,238,413 to $135,040,851,793.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 2285 institutions filings for Q1 2026.

Open SEC evidence

Security key

46120E602

Latest holder period

Q1 2026

13F holders

2,285

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ISRG
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD CAPITAL MANAGEMENT LLC 7.5% $12,413,286,162 26,601,419 Vanguard Capital Management 31 Mar 2026

As of 31 Mar 2026, 2,285 institutional investors reported holding 292,328,806 shares of INTUITIVE SURGICAL INC - Common Stock (ISRG). This represents 82% of the company’s total 355,159,132 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
48%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8.5% 30,075,905 -1.4% 0.24% $13,864,691,498
VANGUARD CAPITAL MANAGEMENT LLC 6.5% 23,079,490 0% 0.26% $10,639,414,096
STATE STREET CORP 4.5% 15,846,973 +0.93% 0.25% $7,305,296,083
PRICE T ROWE ASSOCIATES INC /MD/ 3.5% 12,520,007 -0.28% 0.67% $5,771,599,000
GEODE CAPITAL MANAGEMENT, LLC 2.4% 8,466,851 +2.9% 0.24% $3,887,975,631
Capital World Investors 2.3% 8,048,010 +2.4% 0.51% $3,709,836,542
VANGUARD PORTFOLIO MANAGEMENT LLC 2% 7,233,971 0% 0.17% $3,334,788,291
MORGAN STANLEY 1.7% 6,058,840 +5.5% 0.17% $2,793,066,100
FMR LLC 1.5% 5,477,234 -17% 0.13% $2,524,949,791
JPMORGAN CHASE & CO 1.3% 4,593,894 +13% 0.14% $2,080,000,736
WELLINGTON MANAGEMENT GROUP LLP 1.1% 3,959,290 +15% 0.34% $1,825,193,097
Fisher Asset Management, LLC 1.1% 3,852,940 +1.8% 0.6% $1,776,167,180
ALLIANCEBERNSTEIN L.P. 1.1% 3,812,663 +2.5% 0.71% $2,159,339,817
Invesco Ltd. 1.1% 3,737,430 -9.5% 0.26% $1,722,917,808
BANK OF AMERICA CORP /DE/ 1% 3,616,973 +3.3% 0.12% $1,667,388,335
Bank of New York Mellon Corp 1% 3,550,375 -9.4% 0.3% $1,636,687,619
NORTHERN TRUST CORP 0.99% 3,504,272 -0.63% 0.21% $1,615,434,349
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.93% 3,316,258 +13% 0.32% $1,528,761,776
JENNISON ASSOCIATES LLC 0.86% 3,041,010 -5.2% 0.96% $1,401,875,119
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 2,623,702 +2.7% 0.18% $1,209,500,385
Nuveen, LLC 0.74% 2,621,423 -4% 0.33% $1,208,449,789
BAILLIE GIFFORD & CO 0.72% 2,567,565 +0.64% 1.2% $1,183,621,789
Legal & General Group Plc 0.7% 2,483,660 +1.1% 0.26% $1,144,942,419
GOLDMAN SACHS GROUP INC 0.69% 2,451,269 +1.4% 0.15% $1,130,010,518
Amundi 0.68% 2,428,356 +8.6% 0.3% $1,119,447,834

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 292,328,806 $135,040,851,793 -$3,247,808,601 $460.99 2,285
2025 Q4 298,637,632 $168,934,238,413 +$3,342,099,907 $566.36 2,397
2025 Q3 292,028,731 $130,254,355,689 -$5,828,754,642 $447.23 2,096
2025 Q2 302,212,870 $164,103,806,046 +$2,498,386,496 $543.41 2,239
2025 Q1 297,828,462 $147,452,497,410 -$2,920,638,650 $495.27 2,168
2024 Q4 303,187,590 $158,388,093,720 +$577,313,980 $521.96 2,110
2024 Q3 300,173,813 $147,375,603,417 -$1,552,730,520 $491.27 1,932
2024 Q2 303,379,619 $134,939,105,070 +$2,368,887,534 $444.85 1,801
2024 Q1 298,220,050 $118,921,599,882 +$1,531,564,281 $399.09 1,720
2023 Q4 295,650,122 $99,745,629,692 +$429,258,102 $337.36 1,661
2023 Q3 294,379,759 $86,004,667,518 -$556,389,854 $292.29 1,538
2023 Q2 293,728,647 $100,399,538,047 +$1,150,293,545 $341.94 1,533
2023 Q1 292,167,449 $74,609,737,827 -$322,787,328 $255.47 1,396
2022 Q4 294,224,979 $78,065,985,062 +$476,772,215 $265.35 1,413
2022 Q3 294,489,616 $55,297,156,896 -$267,694,633 $187.44 1,269
2022 Q2 295,634,259 $59,355,375,566 -$753,776,555 $200.71 1,299
2022 Q1 299,445,314 $90,277,385,945 -$175,204,516 $301.68 1,443
2021 Q4 300,090,509 $107,808,912,746 +$68,475,148,753 $359.30 1,501
2021 Q3 95,405,300 $94,845,072,771 -$1,431,185,121 $994.15 1,295
2021 Q2 100,969,651 $92,867,870,671 +$824,363,752 $919.64 1,313
2021 Q1 100,413,108 $74,216,852,097 -$940,447,395 $738.94 1,245
2020 Q4 101,760,120 $83,221,466,403 -$899,722,610 $818.10 1,237
2020 Q3 102,711,755 $72,826,965,266 +$120,708,821 $709.54 1,141
2020 Q2 102,456,598 $58,484,578,891 +$496,489,858 $569.83 1,034
2020 Q1 101,700,582 $50,378,431,495 +$1,083,460,501 $495.21 992
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .